申请人:U C B S.A.
公开号:US04956363A1
公开(公告)日:1990-09-11
A method for the treatment of cognitive and behavioral disorders associated with aging and with dementia syndromes, for example senile dementia, Alzheimer's type, by administering a 2-amino-4-morpholino-6-propyl-1,3,5-triazine of the formula ##STR1## in which R.sub.1 =hydrogen, alkyl, aralkyl or acetyl, R.sub.2 =hydrogen, hydroxyl, alkyl, hydroxyalkyl, alkoxyalkyl, dialkylamino, aryl-hydroxyalkyl, (hydroxycycloalkyl)alkyl, alkanoyloxyalkyl, benzoyloxyalkyl, phenylacetyloxyalkyl, aminocarbonyloxyalkyl, COR.sub.3, where R.sub.3 =alkyl, aryl, halogenoaryl, alkylaryl, alkoxyaryl, aralkyl or aryloxy, CONR.sub.4 R.sub.5, where R.sub.4 and R.sub.5 =hydrogen or alkyl, or R.sub.1 and R.sub.2 form an alkyleneimino substituted by hydroxyalkyl, and in addition when R.sub.1 =acetyl, R.sub.2 =acetoxyalkyl, or a salt thereof.
一种治疗与老化和痴呆综合症相关的认知和行为障碍的方法,例如老年性痴呆、阿尔茨海默氏症,通过给予公式为##STR1## 中R.sub.1=氢、烷基、芳基烷基或乙酰基,R.sub.2=氢、羟基、烷基、羟基烷基、烷氧基烷基、二烷基氨基、芳基-羟基烷基、(羟基环烷基)烷基、脂肪酰氧基烷基、苯甲酰氧基烷基、苯乙酰氧基烷基、氨基甲酰氧基烷基、COR.sub.3,其中R.sub.3=烷基、芳基、卤代芳基、烷基芳基、烷氧基芳基、芳基烷基或芳氧基,CONR.sub.4 R.sub.5,其中R.sub.4和R.sub.5=氢或烷基,或R.sub.1和R.sub.2形成由羟基烷基取代的烷基亚胺基,此外,当R.sub.1=乙酰基时,R.sub.2=乙酰氧基烷基,或其盐。